• Market Capitalisation market-capitalisation-info $12 Mln
  • Price to Earnings Ratio price-to-earning --
  • 12 Month Earnings monthly-earning $-30 Mln

Trevena Inc. (TRVN) Share Price

$0.64

As on 07-Dec-2023 09:42 EST

up-down-arrow $0.023.09%

  • Prev Close info

    $0.63

  • Day's Openinfo

    $0.63

  • Today's Highinfo

    $0.64

  • Today's Lowinfo

    $0.63

  • Today's Volumeinfo

    7,887

  • 52 Week rangeinfo

    $0.51 - 3.28

Please wait...

Trevena Inc. (TRVN) Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Trevena (TRVN)
-54.94 11.30 -35.56 -75.02 -77.81 -47.56 --
S&P BSE Sensex
14.27 7.02 5.53 11.01 15.54 14.51 12.72
#
-- -- -- -- -- -- --
As on 07-Dec-2023  |  #As on
2022
2021
2020
2019
2018
2017
2016
Trevena (TRVN)
-90.19 -72.76 154.49 95.56 -72.93 -72.79 -44.00
S&P BSE Sensex
4.44 21.99 15.75 14.38 5.87 27.91 1.95
S&P BSE Sensex
4.44 21.99 15.75 14.38 5.87 27.91 1.95

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Trevena Inc. (TRVN) Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Trevena Inc. (TRVN)

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other details of Trevena Inc. (TRVN)

        Pres, CEO & Director

        Ms. Carrie L. Bourdow

        Sr. VP & CFO

        Mr. Barry Shin

        Headquarters

        Chesterbrook, PA

        FAQs for Trevena Inc. (TRVN)

        The total asset value of Trevena Inc. (TRVN) stood at $ 46 Mln as on 31-Mar-23

        The share price of Trevena Inc. (TRVN) is $0.64 (NASDAQ) as of 07-Dec-2023 09:42 EST. Trevena Inc. (TRVN) has given a return of -77.81% in the last 3 years.

        Trevena Inc. (TRVN) has a market capitalisation of $ 12 Mln as on 02-Jun-2023. As per Value Research classification, it is a company.

        The P/B ratio of Trevena Inc. (TRVN) is 0.57 times as on 02-Jun-2023, a -0.78% premium to its peers’ median range of 2.54 times.

        Since, TTM earnings of Trevena Inc. (TRVN) is negative, P/E ratio is not available.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Trevena Inc. (TRVN) and enter the required number of quantities and click on buy to purchase the shares of Trevena Inc. (TRVN).

        Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is based in Chesterbrook, Pennsylvania.

        The CEO & director of Ms. Carrie L. Bourdow. is Trevena Inc. (TRVN), and CFO & Sr. VP is Mr. Barry Shin.

        The promoters of Trevena Inc. (TRVN) have pledged 0% of the total equity as on Mar-23.

        Trevena Inc. (TRVN) Ratios
        Return on equity(%)
        -271.18
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        1.33
        Dividend yield(%)
        0

        No, TTM profit after tax of Trevena Inc. (TRVN) was $-30 Mln.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information $11.85 Mln
        • Revenue (TTM)revenue-information $-0.43 Mln
        • Earnings (TTM) earning-information $-30.28 Mln
        • Cash date-information $27.44 Mln
        • Total Debt info $19.60 Mln
        • Insider's Holding 3.34%
        • Liquidity liquidity High
        • 52 Week range week-range $0.51 - 3.28
        • Shares outstanding share-outstanding 10,969,000
        • 10 Years Aggregate:

          CFO: $-439.01 Mln

          EBITDA: $-479.56 Mln

          Net Profit: $-488.76 Mln

        About The Company

        • IPO Date 31-Jan-2014
        • Pres, CEO & Director Ms. Carrie L. Bourdow
        • Sr. VP & CFO Mr. Barry Shin
        • Listing key-listing NASDAQ: TRVN
        • Country United States
        • Headquarters headquarters Chesterbrook, PA
        • Website website https://www.trevena.com
        • Business

          Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G...  protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is based in Chesterbrook, Pennsylvania.  Read more

        Demystifying Stocks.

        At Value Research, we believe it's best to understand investments before diving in. And since 1990, we've been doing exactly that – helping & guiding lakhs of Indians with their investing journey. Join the journey.

        Sign Up for Free
        demystifying-mutual-fund

        What can Value Research do for you?

        solidify-your-fundamentals
        Solidify your fundamentals

        Learn the principles, mindset and tools you need to become a successful Mutual Fund and Stock investor from the masters who have been doing this for decades.

        track-all-your-investments
        Track all your investments

        Use India's most advanced investment tracker to track, analyse and get updates and insights on your investments.

        get-guidance-from-our-experts
        Get guidance from our experts

        Get an analysis of your portfolio along with actionable, general tips and insights, guidance on where to invest based on your goals, and experts' opinions on individual Mutual Funds and Stocks.

        get-access-to-exclusive-analytics
        Get access to exclusive analytics

        Value Research offers the most advanced and detailed data & analytics available on Mutual Funds and Stocks. Sign up and unlock the power yourself.

        Explore it yourself, for free

        Sign up and get access to:

        Unlimited access to advice from India's top experts

        The most comprehensive analysis of funds and stocks in India

        A holistic portfolio manager to help track all your investments easily

        And much more, like guides, tools, webinars, videos and eBooks.

        share-fund-plan-icon